RESUMO
This retrospective, multiple-center study includes 172 PTFE (Gore-Tex) and 35 umbilical vein grafts (Bio-graft) used for femoro-popliteal bypass grafting. The one-year patency rate was approximately 63% in both groups. Until further experience is accumulated, autogenous saphenous vein should probably be the first choice for femoro-popliteal bypass grafting. Prosthetic grafts should preferably be used when the saphenous vein is absent or insufficient.
Assuntos
Bioprótese , Artéria Femoral/cirurgia , Politetrafluoretileno , Artéria Poplítea/cirurgia , Veias Umbilicais/transplante , Idoso , Arteriopatias Oclusivas/cirurgia , Estudos de Avaliação como Assunto , Humanos , Pessoa de Meia-Idade , Sistemas Multi-Institucionais , Estudos RetrospectivosAssuntos
Anticoagulantes/efeitos adversos , Nervo Femoral , Hematoma/induzido quimicamente , Doenças Musculares/induzido quimicamente , Paralisia/induzido quimicamente , Feminino , Nervo Femoral/cirurgia , Hematoma/cirurgia , Heparina/efeitos adversos , Humanos , Pessoa de Meia-Idade , Paralisia/cirurgia , Coxa da PernaRESUMO
A patient is reported who sustained bilaterial iliacus haematoma with femoral nerve palsy during treatment with constant intravenous infustion of heparin for deep venous thrombosis. She was promptly treated with operative decompression and recovered completely from the palsy. Daily examinations of the blood revealed that the plasma heparin concentration, activated partial thromboplastin time, APTT, and thrombin time all were above the therapeutic range at the time when the bleeding started, and before the initial symptoms occurred. Early operative decompression is considered to be the ideal treatment in patients who develop this complication during anticoagulant therapy.